5 Key Takeaways

• 1

  Optometrists should stay informed about new dry eye disease treatments and integrate them into management plans.

• 2

  Reading the TFOS DEWS III report helps optometrists understand new medications and their implementation.

• 3

  Using a DED survey, such as the OSDI-6, can help identify patients who may benefit from new diagnostic testing.

• 4

  Patient testimonials can enhance the credibility of new treatments and should be encouraged by optometrists.

• 5

  Incorporating new treatments can improve patient loyalty and referrals, benefiting both patients and the practice.